Amanote Research
Register
Sign In
Genetic Mutations Predict SMO Inhibitor Response in SHH Medulloblastoma
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2014-076
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
April 3, 2014
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Synthesis of SMO Inhibitor PF-04449913
Synfacts
Otx2 Promotes Granule Cell Precursor Proliferation and SHH-Dependent Medulloblastoma Maintenance in Vivo
Oncogenesis
Cancer Research
Molecular Biology
Mutations and Karyotype Predict Treatment Response in Myelodysplastic Syndromes
American Journal of Hematology
Hematology
Dual Regulatory Functions of SUFU and Targetome of GLI2 in SHH Subgroup Medulloblastoma
Developmental Cell
Biochemistry
Developmental Biology
Genetics
Cell Biology
Molecular Biology
CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma
Cancer Research
Cancer Research
Oncology
Intraventricular Meningiomas Frequently Harbor NF2 Mutations but Lack Common Genetic Alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT
Acta neuropathologica communications
Forensic Medicine
Molecular Neuroscience
Pathology
Neurology
Cellular
Presence of Antigen-Specific Somatic Allelic Mutations and Splice Variants Do Not Predict for Immunological Response to Genetic Vaccination
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Distinct Mutations and Pathways Are Linked to Aromatase Inhibitor Response
Cancer Discovery
Oncology
Correction: Global Genetic Variations Predict Brain Response to Faces
PLoS Genetics
Evolution
Ecology
Genetics
Molecular Biology
Cancer Research
Systematics
Behavior